Tenax Therapeutics Cash Flow Statement (2010-2026) | TENX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	1.96M	3.80M	-62.24M	2.72M	2.86M	2.92M	2.55M	-1.55M	1.37M	1.96M	-12.28M	-3.80M	-3.58M	-3.96M	-6.27M	-10.41M	-10.84M	-15.79M	-15.53M	-15.71M
Depreciation and Depletion (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	895.00	0.00M	0.00M	0.00M	895.00	0.00M
Share-based Compensation (Quarter)												0.12M	0.01M	0.01M	0.84M	4.14M	4.50M	5.50M	4.80M	2.84M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)							0.00M	0.00M	-0.00M		125.00					3.13M	6.06M	3.00	6.62M	7.87M
Asset Writedowns and Impairment (Quarter)
Non-cash Items (Quarter)								-1.72M				-5.17M			0.78M	0.00M	559.00	755.00	41.38M	3.15M
Change in Interest Receivables (Quarter)	-336.00	0.00M	-0.00M	-0.00M	-0.00M
Cash from Operations (Quarter)	-1.85M	-3.02M	-2.77M	-2.94M	-3.43M	-3.33M	-1.69M	-1.72M	-0.92M	-2.08M	-1.18M	-5.20M	-3.00M	-3.08M	-3.52M	-7.00M	-6.20M	-9.20M	-13.40M	-9.30M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.05M	0.03M	-0.07M	0.03M	0.03M	0.03M	0.03M
Depreciation & Amortization (CF) (Quarter)	891.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	895.00	0.00M	969.00	0.01M
Change in Working Capital
Change in Receivables (Quarter)						-1.38M	0.96M	-0.23M	-0.20M	0.78M	-0.04M	0.02M	-0.68M	0.24M	0.36M	-1.22M
Change in Inventory (Quarter)
Change in Account Payables (Quarter)												-1.00M	-0.22M	0.71M	1.57M	-1.32M	-1.28M	5.05M	0.43M	0.30M
Change in Accured Expenses (Quarter)	-0.14M	0.28M	0.10M	0.18M	-0.39M	-0.66M	0.53M	-0.63M	-0.08M	-0.06M	1.00M	-0.48M	0.06M	0.39M	0.56M	-0.61M	1.04M	-0.97M	0.12M	1.02M
Investing Activities
Capital Expenditures (Quarter)	0.00M	0.00M	0.00M	0.01M			-0.00M	0.00M	0.00M
Sales of Property, Plant and Equipment (Quarter)								0.00M	0.00M		157.00
Change in Intangibles (Quarter)
Cash from Investing Activities (Quarter)	-0.02M	0.51M	-0.00M	-0.01M			0.00M	0.00M	0.00M		157.00
Financing Activities
Other financing activities (Quarter)								0.28M				0.34M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)				0.36M			0.26M
Long-Term Debt Repayments (Quarter)				0.14M	0.14M	0.09M	-0.36M	0.11M	0.17M	0.17M	0.17M	0.09M	0.13M	0.28M
Short-Term Debt repayments (Quarter)
Change in Capital Stock
Shares Issued (Quarter)		8.65M					0.00M	0.51M			-0.51M	1.83M	4.70M	-4.70M	-1.76M					0.03M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)		9.19M		0.23M	7.79M	-0.09M	0.00M	14.01M	-0.10M	-0.17M	-0.17M	7.92M	-0.13M	92.01M	0.07M	23.56M	0.28M	3.06M	11.61M	30.50M
Change in Cash (Quarter)	-1.87M	6.68M	-2.77M	-2.72M	4.36M	-3.42M	-1.68M	12.29M	-1.02M	-2.25M	-1.35M	2.76M	-3.17M	88.93M	-3.46M	16.60M	-5.99M	-6.09M	-1.80M	21.19M
Free Cash Flow (Quarter)	-1.85M	-3.02M	-2.77M	-2.94M	-3.43M	-3.33M	-1.68M	-1.73M	-0.92M	-2.08M	-1.18M	-5.20M	-3.00M	-3.08M	-3.52M	-7.00M	-6.20M	-9.20M	-13.40M	-9.30M
Net Cash Flow (Quarter)	-1.87M	6.68M	-2.77M	-2.72M	4.36M	-3.42M	-1.68M	12.29M	-1.02M	-2.25M	-1.35M	2.72M	-3.13M	88.93M	-3.45M	16.56M	-5.92M	-6.14M	-1.79M	21.20M

Research Tools

Tenax Therapeutics Cash Flow Statement (2010-2026) | TENX

Create an account

Sign In

Reset Password